The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The goal is to create a drug delivery system capable of effectively treating implant-related infections, which pose significant challenges in military medicine and healthcare more broadly. This award reflects the program's emphasis on supporting high-impact biomedical research to improve health outcomes for service members, veterans, and the general public.
Generated 12/3/24, 9:10 AM